Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Physical ablation via the photothermal effect on water-rich tissue refers to a **non-pharmacological therapeutic approach** that uses focused light energy—typically from lasers in the near-infrared region—to induce rapid heating within biological tissues. The primary mechanism involves absorption of light by water molecules and/or exogenous photothermal agents (such as gold or palladium nanoparticles), which convert this energy into heat. When local temperatures rise sufficiently fast and high, this leads to **cellular destruction through protein denaturation, membrane disruption, and vaporization**, effectively ablating targeted areas such as tumors or infected/injured tissues[1][2][3][4]. This method is widely used for minimally invasive treatment of cancers (e.g., liver tumors), infection control in wound care using hydrogels with embedded photothermal agents, and other applications where precise localized tissue removal is desired. The efficacy depends strongly on laser parameters (wavelength, power density), exposure time, presence/absence of exogenous chromophores/agents, and the optical properties of the target tissue. Importantly: This entry does not describe a conventional molecular target such as an enzyme or receptor; rather it describes a physical process applied at the cellular/tissue level. Therefore it should not be classified as a "therapeutic target" in standard pharmacological terms—it lacks canonical gene/protein structure and does not interact with drugs via classic ligand-receptor mechanisms. Regarding interacting drugs, photothermal ablation is a physical process, not a molecular target for drugs; however, it may be combined with agents such as photothermal agents (e.g., gold nanoparticles, palladium nanoparticles) to enhance the effect[1][2]. There are no specific biomarkers for this process; patient selection may depend on imaging or anatomical criteria. "The primary mechanism for ablation...is a volumetric photothermal process...energy densities within bulk material result in rapid temperature increases causing vaporization/ejection"[4]. "Photothermal hydrogels have excellent applications...controlling infection...repairing various tissue defects...[the] local temperature produced by the photothermal effect can be modulated by adjusting light irradiation parameters..."[1]. "Nanoparticle-mediated photothermal effect shows great potential as noninvasive method for cancer therapy treatment..."[2]. In summary: This entry describes an important clinical technique but does **not** represent a discrete molecular entity suitable for structured drug-target databases.
The mechanism is not drug-target based but involves conversion of light energy to heat by exogenous or endogenous chromophores in water-rich tissues, leading to rapid temperature rise and cell/tissue destruction[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physical ablation via photothermal effect on water-rich tissue.